decemb
novel
coronaviru
discov
identifi
viral
pneumonia
case
occur
wuhan
hubei
provinc
china
name
world
health
organ
januari
follow
month
quickli
spread
insid
outsid
hubei
provinc
even
countri
sharp
increas
case
number
caus
widespread
panic
among
peopl
medic
profession
requir
uptod
guidelin
follow
urgent
healthcar
problem
emerg
respons
request
reliabl
advic
frontlin
clinician
public
healthcar
profession
manag
pandem
develop
rapid
advanc
guidelin
involv
diseas
epidemiolog
etiolog
diagnosi
treatment
nurs
hospit
infect
control
clinician
also
public
health
worker
commun
resid
guidelin
develop
group
multidisciplinari
compos
individu
health
profession
methodologist
health
profession
includ
frontlin
clinic
doctor
nurs
work
depart
respiratori
medicin
fever
clinic
critic
medicin
emerg
infecti
diseas
expert
respiratori
infecti
diseas
hospit
manag
board
methodologist
includ
methodologist
guidelin
develop
systemat
review
literatur
search
profession
guidelin
suitabl
frontlin
doctor
nurs
manag
hospit
healthcar
section
healthi
commun
resid
personnel
public
healthcar
relev
research
person
interest
manag
guidelin
aim
serv
healthcar
profession
tackl
suspect
infect
case
confirm
infect
case
cluster
infect
case
close
contact
suspici
exposur
infect
case
oral
inquiri
financi
interest
relev
person
conduct
first
meet
start
guidelin
relev
financi
well
nonfinanci
interest
survey
disclos
subsequ
assess
consensu
confer
order
minim
potenti
bia
guidelin
develop
final
conflict
interest
personnel
particip
prepar
guidelin
guidelin
rapid
guidelin
respond
emerg
infecti
diseas
due
urgent
need
tight
work
schedul
conduct
widerang
survey
discuss
meet
frontlin
clinician
manag
patient
infect
final
guidelin
topic
key
question
consid
lack
direct
evid
newli
identifi
infect
search
refer
guidelin
relat
sar
sever
acut
respiratori
syndrom
mer
middl
east
respiratori
syndrom
influenza
also
refer
guidelin
newlyissu
nation
health
commiss
peopl
republ
china
addit
independ
literatur
search
team
search
avail
indirect
evid
systemat
review
andor
rct
random
control
trial
treatment
chemoprophylaxi
sar
mer
influenza
viru
infect
exist
evid
address
topic
question
cover
guidelin
qualiti
assess
lack
higherlevel
qualiti
evid
panel
consid
observ
studi
case
seri
limit
time
perform
new
systemat
review
identifi
relev
literatur
januari
search
bibliograph
databas
pubm
embas
cochran
librari
also
search
follow
websit
http
wwwwhoint
cdc
center
diseas
control
prevent
http
wwwcdcgov
nice
nation
institut
health
clinic
excel
http
wwwniceorguk
nation
health
commiss
peopl
republ
china
http
wwwnhcgovcn
nation
administr
tradit
chines
medicin
http
wwwsatcmgovcn
newli
identifi
pathogen
respons
outbreak
pandem
diseas
suffici
evid
reveal
whole
natur
viru
situat
obtain
evid
expert
fight
diseas
frontlin
effici
main
sourc
januari
person
screen
identifi
suspect
infecti
victim
diagnos
includ
critic
condit
infect
zhongnan
hospit
wuhan
univers
process
frontlin
clinician
nurs
accumul
valuabl
experi
diagnosi
treatment
nurs
infect
patient
henc
experi
assess
use
expert
evid
guidelin
develop
took
interview
group
survey
collect
inform
treatment
evid
guidelin
panel
meet
could
integr
guidelin
panel
summari
find
see
addit
file
expert
evid
solicit
descript
case
report
summari
report
topic
question
case
manag
accord
grade
recommend
assess
develop
evalu
grade
basic
approach
rule
particularli
consid
expert
evid
assess
qualiti
bodi
evid
make
recommend
qualiti
evid
reflect
whether
extent
confid
estim
effect
adequ
support
particular
recommend
level
evid
categor
high
qualiti
moder
qualiti
low
qualiti
low
qualiti
recommend
classifi
strong
weak
strong
recommend
alway
mean
suffici
intervent
effect
besid
effect
intervent
form
recommend
base
sever
diseas
patient
willing
safeti
econom
see
tabl
meet
expert
evid
collect
systemat
avail
panel
member
evid
identifi
assess
recommend
formul
base
evid
facetofac
meet
panel
member
supplement
expert
particip
panel
meet
expert
evid
highli
valu
guidelin
develop
consensu
process
evid
agre
frontlin
clinician
consensu
meet
consid
highqual
evid
specif
recomend
use
strongli
recommend
strong
recommend
wherea
suggest
consid
use
weak
one
guidelin
publish
chines
english
version
time
due
space
limit
current
standard
revis
includ
evid
descript
full
revis
publish
new
medicin
chines
name
yixu
xinzhi
http
wwwjnewmedcom
volum
issu
sinc
decemb
multipl
case
occur
unexplain
pneumonia
success
report
hospit
wuhan
citi
histori
exposur
larg
hua
nan
seafood
market
wuhan
citi
hubei
provinc
china
confirm
acut
respiratori
infect
caus
novel
coronaviru
far
number
case
without
histori
hua
nan
seafood
market
exposur
increas
addit
cluster
case
confirm
case
without
histori
travel
wuhan
emerg
also
confirm
case
without
clear
exposur
wuhan
seafood
market
found
mani
foreign
countri
region
januari
nation
health
commiss
peopl
republ
china
record
total
confirm
case
pneumonia
infect
provinc
district
citi
includ
sever
case
death
total
case
cure
discharg
present
suspect
case
record
close
contact
confirm
patient
track
peopl
releas
medic
observ
day
peopl
still
undergo
medic
observ
total
confirm
case
report
hong
kong
macao
taiwan
china
case
hong
kong
case
macao
case
taiwan
addit
confirm
case
report
abroad
thailand
australia
singapor
franc
japan
korea
malaysia
unit
state
vietnam
one
nepal
wild
anim
bat
possibl
host
requir
confirm
whether
pneumonia
infect
transmit
directli
bat
intermedi
host
believ
clarifi
sourc
viru
help
determin
zoonot
transmiss
pattern
present
main
infect
sourc
patient
pneumonia
infect
respiratori
droplet
transmiss
main
rout
transmiss
also
transmit
contact
although
mani
detail
sourc
viru
abil
spread
peopl
remain
unknown
increas
number
case
show
sign
humantohuman
transmiss
isol
lower
respiratori
tract
patient
unexplain
pneumonia
wuhan
novel
coronaviru
belong
genu
envelop
particl
round
oval
often
polymorph
diamet
nm
nm
genet
characterist
significantli
differ
sarsrcov
sar
relat
coronavirus
mersrcov
mer
relat
coronavirus
current
research
show
homolog
sarsrcov
found
human
respiratori
epitheli
cell
h
vitro
isol
cultur
take
day
cell
line
sourc
viru
time
span
patient
discharg
infect
viru
pathogenesi
still
clear
evid
viral
mutat
found
far
necessari
obtain
much
clinic
isol
virus
time
geograph
varieti
assess
extent
viru
mutat
also
whether
mutat
indic
adapt
human
host
base
current
epidemiolog
survey
latenc
period
gener
day
maximum
day
unlik
sarsrcov
contagi
latenc
period
popul
gener
suscept
viru
elderli
underli
diseas
show
seriou
condit
infect
children
infant
also
get
infect
current
knowledg
case
patient
good
prognosi
symptom
children
rel
mild
patient
critic
condit
death
case
frequent
seen
elderli
chronic
underli
diseas
newest
studi
includ
first
confirm
case
admit
wuhan
decemb
januari
show
median
age
patient
year
main
underli
diseas
diabet
hypertens
cardiovascular
diseas
case
experienc
acut
respiratori
distress
syndrom
ard
case
admit
intens
care
unit
icu
case
die
patient
follow
clinic
featur
epidemiolog
risk
clinic
featur
fever
imag
featur
pneumonia
normal
reduc
white
blood
cell
count
reduc
lymphocyt
count
earli
stage
diseas
onset
epidemiolog
risk
histori
travel
resid
wuhan
citi
china
citi
continu
transmiss
local
case
last
day
symptom
onset
contact
patient
fever
respiratori
symptom
wuhan
citi
china
citi
continu
transmiss
local
case
last
day
symptom
onset
epidemiolog
connect
infect
cluster
onset
one
follow
pathogen
evid
confirm
case
posit
realtim
pcr
test
nucleic
acid
respiratori
blood
sampl
viral
gene
sequenc
show
highli
homogen
known
respiratori
blood
sampl
suspect
cluster
case
defin
one
confirm
case
time
one
case
fever
respiratori
infect
found
small
area
famili
construct
site
unit
etc
within
day
circumst
confirm
case
found
possibl
humantohuman
transmiss
due
close
contact
infect
due
coexposur
determin
cluster
case
one
follow
contact
onset
confirm
case
absenc
effect
protect
live
studi
work
close
contact
confirm
case
close
contact
work
close
share
classroom
live
hous
confirm
case
medic
nurs
staff
famili
member
live
treat
nurs
visit
confirm
case
personnel
similar
close
contact
case
provid
direct
treatment
care
case
visit
case
stay
close
environ
case
locat
patient
caregiv
room
case
peopl
close
contact
patient
transport
vehicl
includ
taken
care
patient
vehicl
person
compani
patient
famili
member
colleagu
friend
etc
passeng
traffic
staff
consid
like
close
contact
patient
investig
evalu
circumst
consid
close
contact
person
close
contact
patient
profession
investig
evalu
person
suspici
exposur
expos
without
effect
protect
process
sale
handl
distribut
administr
manag
wild
anim
materi
environ
posit
test
person
close
contact
suspici
exposur
advis
health
observ
period
start
last
day
contact
infect
patient
suspici
environment
exposur
display
symptom
especi
fever
respiratori
symptom
cough
short
breath
diarrhea
reach
medic
attent
immedi
contact
surveil
carri
expos
accident
contact
lowlevel
exposur
suspect
confirm
patient
ie
check
potenti
symptom
carri
daili
activ
see
tabl
detail
patient
suspect
infect
isol
monitor
diagnos
hospit
soon
possibl
doctor
make
recommend
base
patient
situat
patient
mild
symptom
suspect
infect
may
consid
inhom
isol
home
care
weak
recommend
suspect
infect
sever
symptom
need
stay
hospit
observ
doctor
judgment
follow
isol
guidelin
suspect
patient
see
tabl
detail
also
note
whether
suspect
patient
given
inhom
isol
care
requir
care
clinic
evalu
safeti
assess
profession
suspect
patient
get
improv
symptom
even
worsen
condit
home
care
need
go
doctor
treatment
period
home
care
patient
medic
symptom
close
record
caregiv
also
monitor
bodi
temperatur
daili
throughout
period
home
care
healthcar
personnel
perform
regular
eg
daili
followup
facetofac
visit
phone
interview
ideal
feasibl
follow
progress
symptom
necessari
specif
diagnost
test
conduct
intern
visitor
take
routin
precaut
enter
leav
affect
area
includ
avoid
close
contact
peopl
acut
respiratori
infect
wash
hand
frequent
especi
contact
sick
surround
environ
follow
appropri
cough
etiquett
avoid
close
contact
live
dead
farm
anim
bat
wild
anim
passeng
avoid
unnecessari
travel
possibl
travel
hubei
provinc
especi
wuhan
citi
past
day
fever
cough
difficulti
breath
see
doctor
immedi
call
doctor
hisher
recent
trip
symptom
go
doctor
offic
emerg
room
avoid
contact
other
travel
around
cover
mouth
nose
tissu
sleev
hand
cough
sneez
wash
hand
soap
water
least
soap
water
avail
use
alcoholbas
hand
sanit
infect
case
symptom
like
fever
fatigu
dri
cough
dyspnea
etc
without
nasal
congest
runni
nose
upper
respiratori
symptom
despit
atyp
symptom
report
nanshan
zhong
academician
chines
academi
engin
exclus
interview
xinhua
news
agenc
januari
point
fever
still
typic
symptom
infect
patient
mild
symptom
may
present
posit
sign
patient
sever
condit
may
short
breath
moist
rale
lung
weaken
breath
sound
dull
percuss
increas
decreas
tactil
speech
tremor
etc
imag
find
vari
patient
age
immun
statu
diseas
stage
time
scan
underli
diseas
drug
intervent
imag
featur
lesion
show
domin
distribut
mainli
subpleur
along
bronchial
vascular
bundl
quantiti
often
three
lesion
occasion
singl
doubl
lesion
shape
patchi
larg
block
nodular
lumpi
honeycomblik
gridlik
cordlik
etc
densiti
mostli
uneven
pave
stoneslik
chang
mix
ground
glass
densiti
interlobular
septal
thicken
consolid
thicken
bronchial
wall
etc
concomit
sign
vari
airbronchogram
rare
pleural
effus
mediastin
lymph
node
enlarg
etc
multipl
patchi
subsegment
segment
groundglass
densiti
shadow
lung
classifi
pave
stonelik
chang
finegrid
small
honeycomblik
thicken
interlobular
septa
thinner
ct
scan
layer
clearer
groundglass
opac
thicken
interlobular
septa
display
slightli
highdens
groundglass
chang
fuzzi
edg
finegrid
small
honeycomblik
thicken
interlobular
septa
present
highresolut
comput
tomographi
hrct
fig
case
total
case
resolut
xray
wors
lower
ct
resolut
basic
manifest
groundglass
opac
fuzzi
edg
fig
case
total
case
multipl
patchi
larg
patch
consolid
lung
littl
gridlik
honeycombshap
interlobular
septal
thicken
especi
middl
lower
lobe
fig
case
total
case
common
elderli
sever
condit
patient
singl
multipl
extens
subpleur
gridlik
honeycomblik
thicken
interlobular
septum
thicken
bronchial
wall
tortuou
thick
strandlik
opac
sever
patchi
consolid
occasion
small
amount
pleural
effus
enlarg
mediastin
lymph
node
seen
fig
case
total
case
mostli
seen
elderli
singl
multipl
solid
nodul
consolid
nodul
center
lobul
surround
groundglass
opac
fig
case
total
case
ct
imag
demonstr
stage
accord
time
onset
respons
bodi
viru
includ
ultraearli
stage
stage
usual
refer
stage
patient
without
clinic
manifest
neg
laboratori
test
posit
throat
swab
within
week
expos
viruscontamin
environ
histori
contact
patient
patientrel
famili
member
unit
medic
staff
cluster
environ
main
imag
manifest
singl
doubl
scatter
focal
groundglass
opac
nodul
locat
central
lobul
surround
patchi
groundglass
opac
patchi
consolid
sign
intrabronchi
airbronchogram
domin
middl
lower
pleura
fig
case
total
case
earli
stagethi
stage
refer
period
day
clinic
manifest
fever
cough
dri
cough
etc
patholog
process
stage
dilat
congest
alveolar
septal
capillari
exud
fluid
alveolar
caviti
interlobular
interstiti
edema
show
singl
multipl
scatter
patchi
agglomer
groundglass
opac
separ
honeycomblik
gridlik
thicken
interlobular
septa
fig
case
total
case
rapid
progress
stage
stage
refer
period
day
clinic
manifest
start
patholog
featur
stage
accumul
larg
number
cellrich
exud
alveolar
caviti
vascular
expans
exud
interstitium
lead
aggrav
alveolar
interstiti
edema
fibrou
exud
connect
alveolu
interalveolar
space
form
fusion
state
ct
manifest
fuse
largescal
light
consolid
airbronchogram
insid
fig
case
total
case
consolid
stage
stage
refer
period
around
day
clinic
manifest
appear
main
patholog
featur
stage
fibrou
exud
alveolar
caviti
disappear
capillari
congest
alveolar
wall
ct
imag
show
multipl
patchi
consolid
slighter
densiti
smaller
rang
previou
stage
fig
case
total
case
dissip
stage
stage
refer
period
roughli
week
onset
clinic
manifest
rang
lesion
reduc
ct
imag
show
patchi
consolid
striplik
opac
time
goe
show
gridlik
thicken
interlobular
septum
thicken
striplik
twist
bronchial
wall
scatter
patchi
consolid
fig
case
total
case
mainli
distinguish
known
viral
viru
pneumonia
influenza
virus
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
rhinoviru
human
metapneumoviru
sarsrcov
etc
also
mycoplasma
pneumonia
chlamydia
pneumonia
bacteri
pneumonia
addit
distinguish
noninfecti
diseas
vascul
dermatomyos
organ
pneumonia
earli
stage
diseas
total
number
leukocyt
decreas
keep
normal
decreas
lymphocyt
count
increas
normal
monocyt
high
attent
paid
situat
absolut
valu
lymphocyt
less
number
cell
significantli
decreas
gener
recommend
recheck
blood
routin
chang
day
flu
antigen
present
routin
detect
flu
antigen
b
sampl
throat
swab
conduc
earli
rapid
screen
flu
fast
test
rel
high
fals
neg
raterespiratori
viru
nucleic
acid
detect
respiratori
viru
nucleic
acid
commonli
use
detect
infect
common
respiratori
virus
mycoplasma
chlamydia
infect
adenoviru
parainfluenza
viru
respiratori
syncyti
viru
mycoplasma
chlamydia
influenza
influenza
b
viru
nucleic
acid
detect
accur
rna
detect
diagnost
valu
strong
recommend
rna
posit
throat
swab
sampl
respiratori
tract
sampl
fluoresc
quantit
pcr
method
especi
multipl
sampl
detect
kit
exclud
sampl
qualiti
sampl
collect
time
contaminatori
technic
problem
great
support
etiolog
diagnosisoth
laboratori
test
laboratori
test
statu
infect
includ
blood
ga
analysi
liver
kidney
function
myocardi
enzym
myoglobin
erythrocyt
sediment
rate
esr
creactiv
protein
crp
procalcitonin
pct
lactat
ddimer
coagul
imag
urin
routin
test
inflammatori
factor
interleukin
il
tnf
item
tuberculosi
tb
subgroup
complement
antiacid
stain
etc
blood
ga
analysi
help
judg
oxygen
moderatelyil
sever
patient
combin
increas
lactic
acid
feasibl
screen
patient
highrisk
oxygen
disord
infect
patient
increas
liver
enzym
muscl
enzym
esr
myoglobin
detect
crp
pct
certain
valu
distinguish
whether
bacteri
infect
lung
ddimer
sever
patient
significantli
increas
epidem
frequent
clot
disord
microthrombot
format
peripher
blood
vessel
detect
inflammatori
factor
may
help
preliminarili
evalu
immun
statu
patient
earli
stage
diseas
total
number
leukocyt
peripher
blood
normal
decreas
lymphocyt
count
decreas
patient
liver
enzym
transaminas
creatin
kinas
ck
myoglobin
increas
crp
esr
increas
pct
normal
patient
increas
ddimer
occur
sever
case
data
first
patient
infect
hospit
zhongnan
hospit
wuhan
univers
collect
analysi
reveal
averag
valu
white
blood
cell
wbc
plt
lymphocyt
monocyt
averag
valu
alt
alanin
aminotransferas
ul
ast
aspart
aminotransferas
ul
averag
valu
ck
ul
esr
mmh
crp
mgl
pgml
ddimer
ngml
compar
healthi
checkup
absolut
valu
lymphocyt
vs
lymphocyt
percentag
vs
eosinophil
percentag
vs
absolut
valu
vs
patient
significantli
reduc
p
absolut
number
vs
percentag
vs
increas
patient
p
percentag
monocyt
increas
slightli
vs
absolut
number
monocyt
chang
significantli
vs
next
gener
sequenc
ng
electron
microscop
technolog
play
role
earli
diagnosi
diagnost
valu
weaken
discoveri
specif
nucleic
acid
detect
technolog
addit
ng
detect
tell
whether
pathogen
mutat
suspect
confirm
case
need
treat
design
hospit
effect
isol
protect
condit
suspect
case
need
treat
separ
singl
room
confirm
case
admit
ward
critic
case
admit
icu
soon
possibl
patient
rest
bed
monitor
vital
sign
heart
rate
puls
oxygen
satur
respiratori
rate
blood
pressur
given
support
treatment
ensur
suffici
energi
intak
balanc
water
electrolyt
acidbas
level
intern
environ
factor
strong
recommend
patient
monitor
blood
routin
crp
pct
organ
function
liver
enzym
bilirubin
myocardi
enzym
creatinin
urea
nitrogen
urin
volum
etc
coagul
function
arteri
blood
ga
analysi
chest
imag
strong
recommend
patient
given
effect
oxygen
therapi
includ
nasal
cathet
mask
oxygen
high
flow
nasal
oxygen
therapi
hfno
noninvas
ventil
niv
invas
mechan
ventil
strong
recommend
first
oxygen
therapi
choic
patient
sever
respiratori
infect
respiratori
distress
hypoxemia
shock
initi
flow
rate
lmin
titrat
flow
rate
reach
target
oxygen
satur
adult
nonpregn
patient
pregnant
patient
children
children
obstruct
dyspnea
apnea
sever
respiratori
distress
central
cyanosi
shock
coma
convuls
children
second
respiratori
support
given
patient
hypox
respiratori
failur
acut
respiratori
distress
syndrom
hfno
niv
select
nasal
cannula
mask
oxygen
therapi
ineffect
patient
hypox
respiratori
failur
howev
patient
hypercapnia
acut
exacerb
chronic
obstruct
pulmonari
diseas
cardiogen
pulmonari
edema
hemodynam
instabl
multipl
organ
failur
abnorm
mental
statu
hfno
oxygen
routin
adopt
measur
respiratori
failur
improv
worsen
continu
within
short
time
h
use
hfno
niv
intub
perform
immedi
low
tidal
volum
mlkg
low
suction
pressur
platform
pressur
use
invas
mechan
ventil
suggest
posit
endexpiratori
pressur
peep
high
posit
endexpiratori
pressur
use
patient
moder
sever
acut
respiratori
distress
syndrom
peep
titrat
accord
maintain
order
improv
alveolar
atelectasi
reduc
alveolar
hyperexpans
pulmonari
vascular
resist
end
inspir
sever
patient
ard
recommend
ventil
prone
posit
hd
extracorpor
membran
oxygen
ecmo
consid
patient
refractori
hypoxemia
difficult
correct
protect
lung
ventil
strong
recommend
present
evid
rct
support
specif
drug
treatment
new
coronaviru
suspect
confirm
casesth
atom
inhal
consid
million
u
per
time
adult
steril
inject
water
twice
day
weak
recommend
lopinavirritonavir
oral
capsul
time
twice
day
also
consid
weak
recommend
lowlevel
evid
includ
retrospect
cohort
histor
control
studi
case
report
case
seri
reveal
lopinavirritonavir
alon
combin
antivir
produc
certain
benefit
treatment
sar
mer
reduc
incid
mortal
ard
recent
systemat
review
show
lopinavirritonavir
anticoronaviru
effect
mainli
seen
earli
applic
reduc
patient
mortal
reduc
glucocorticoid
consumpt
howev
earli
treatment
window
miss
signific
effect
late
applic
realworld
studi
still
need
explor
clinic
effect
earli
use
infect
pneumonia
effect
combin
use
antivir
still
controversi
principl
avoid
blind
inappropri
use
antibacteri
drug
especi
combin
broadspectrum
antibacteri
drug
enhanc
bacteriolog
surveil
perform
promptli
given
appropri
antibacteri
drug
occur
secondari
bacteri
infectionaccord
clinic
manifest
patient
accompani
bacteri
infect
rule
mild
patient
take
antibacteri
drug
communityacquir
pneumonia
amoxicillin
azithromycin
fluoroquinolon
empir
antibacteri
treatment
sever
patient
cover
possibl
pathogen
deescal
therapi
pathogen
bacteria
clarifi
use
corticosteroid
sever
ard
controversi
therefor
system
use
glucocorticoid
need
cautiou
methylprednisolon
use
appropri
patient
rapid
diseas
progress
sever
ill
accord
sever
diseas
mg
methylprednisolon
per
day
consid
total
daili
dose
exceed
mgkg
weak
recommend
sar
manag
relat
research
show
time
use
noninvas
continu
posit
airway
pressur
corticosteroid
effect
strategi
increas
lung
shadow
increas
dyspnea
appropri
use
glucocorticoid
abl
significantli
improv
clinic
symptom
patient
sar
reduc
degre
diseas
progress
acceler
absorpt
lung
lesion
shorten
length
hospit
stay
cautiou
hormon
therapi
incid
advers
reaction
symptomat
treatment
fever
temperatur
higher
ibuprofen
use
antipyret
oral
g
per
time
use
everi
h
continu
fever
time
h
temperatur
accept
much
lower
bodi
temperatur
conduc
antivir
treatmentnutrit
support
treatment
inpati
screen
nutrit
risk
base
score
admit
hospit
recommend
plan
patient
differ
nutrit
risk
score
follow
first
total
score
point
recommend
eat
proteinrich
food
egg
fish
lean
meat
dairi
product
carbohydratecontain
diet
suppos
ideal
energi
intak
kcal
protein
mass
g
second
total
score
point
patient
given
nutrit
support
earli
possibl
recommend
increas
protein
intak
oral
nutrit
supplement
timesday
g
proteintim
order
reach
mount
g
proteintim
protein
powder
ad
basi
standard
whole
protein
prepar
enter
nutrit
tube
place
patient
intak
supplement
nutrit
oral
routinereduc
incid
stress
ulcer
gastrointestin
bleed
use
receptor
antagonist
proton
pump
inhibitor
patient
gastrointestin
bleed
risk
factor
risk
factor
gastrointestin
bleed
includ
mechan
ventil
h
coagul
dysfunct
renal
replac
therapi
liver
diseas
variou
complic
higher
score
organ
failurereduc
secret
lung
gland
improv
respiratori
function
patient
dyspnea
cough
wheez
respiratori
distress
syndrom
due
increas
respiratori
gland
secret
recommend
use
select
receptor
anticholinerg
drug
reduc
secret
relax
smooth
muscl
airway
reliev
airway
spasm
improv
pulmonari
ventilationreduc
incid
venou
embol
evalu
risk
venou
embol
patient
use
lowmolecularweight
heparin
heparin
highrisk
patient
without
contraind
treat
patient
base
syndrom
differenti
individu
prevent
ill
better
treatment
get
diseas
commun
implement
relev
nation
regul
take
great
effort
keep
away
contamin
materi
disinfect
environ
improv
healthcar
managementindividu
recommend
take
food
proper
amount
balanc
nutrit
regular
daili
life
physic
activ
avoid
overload
workpsycholog
develop
proper
interest
career
mutual
promot
mannerdrug
includ
ifumig
moxa
room
min
per
dayiiwear
perfum
chines
herb
bag
clove
fineleaf
schizonepeta
herb
perilla
frutescen
atractylod
lancea
cinnamon
biond
magnolia
flower
asarum
sieboldii
elettaria
cardamomum
g
crush
powder
put
bag
extern
use
chang
new
one
everi
day
iiiprescript
chines
herb
feet
bath
vulgari
g
carthamu
g
dri
ginger
g
soak
herb
boil
water
bath
feet
medic
liquid
temperatur
suitabl
soak
feet
minivprescript
chines
herb
prophylaxi
astragalu
mongholicu
g
roast
rhizoma
atractylodi
macrocephala
g
saposhnikovia
divaricata
g
cyrtomium
fortunei
g
honeysuckl
g
dri
tangerin
orang
peel
g
eupatorium
g
licoric
g
take
medicin
yield
decoct
day
adult
day
treatment
cours
children
cut
dose
halfvmed
tea
perilla
leaf
g
agastach
leaf
g
dri
tangerin
orang
peel
g
stew
amomum
tsaoko
g
slice
ginger
soak
herb
hot
water
drink
water
like
enjoy
teavichines
patent
medicin
huoxiang
zhengqi
capsul
huoxiang
zhengqi
shui
half
dose
two
clinic
symptom
period
includ
clinic
symptom
hypodynamia
accompani
gastrointestin
upset
recommend
chines
patent
medicin
huoxiang
zhengqi
capsul
ball
liquid
oral
liquid
clinic
symptom
hypodynamia
fever
recommend
chines
patent
medicin
jinhua
qinggan
granul
lianhua
qingwen
capsul
granul
shufeng
jiedu
capsul
granul
fangfeng
tongsheng
pill
granul
period
involv
stage
includ
earlystag
character
exterior
syndrom
colddamp
stage
clinic
manifest
present
follow
avers
cold
without
sweat
headach
gener
heavi
limb
pain
glomu
full
chest
diaphragm
thirst
desir
drink
ungratifi
loos
stool
yellow
urin
frequent
micturit
yellow
urin
therapeut
logic
dissip
cold
elimin
damp
recommend
prescript
huoxiang
zhengqi
powder
yin
damp
injur
superfici
case
nation
famou
tradit
chines
medic
doctor
medic
case
compris
perilla
leaf
g
atractylod
lancea
g
radix
angelica
dahurica
g
dri
tangerin
orang
peel
g
notopterygium
root
g
agastach
rugosu
g
end
addit
mangnolia
officinali
g
saposhnikovia
divaricata
g
poria
peel
g
tetrapanax
papyriferu
g
yield
decoct
addit
recommend
chines
patent
medicin
huoxiang
zhengqi
capsul
huoxiang
zhengqi
shuiearlystag
character
colddamp
obstruct
lung
stage
clinic
manifest
present
follow
avers
cold
without
fever
dri
cough
dri
throat
fatigu
hypodynamia
oppress
chest
epigastr
full
nausea
loos
stool
tongu
pale
reddish
tongu
fur
slimi
white
soggi
puls
henc
therapeut
logic
dissip
cold
resolv
obstruct
recommend
prescript
compris
atractylod
lancea
g
dri
tangerin
orang
peel
g
mangnolia
officinali
g
agastach
rugosu
g
end
addit
amomum
tsaoko
g
ephedra
herb
g
notopterygium
root
g
ginger
g
arecanut
g
end
addit
periostracum
cicada
g
bombyx
batryticatu
g
rhizoma
curcuma
longa
g
yield
decoctionmiddlestag
character
epidem
toxin
block
lung
stage
clinic
manifest
includ
persist
fever
altern
cold
heat
cough
less
phlegm
yellow
phlegm
abdomin
distens
constip
oppress
chest
anhel
cough
wheez
pant
exert
red
tongu
slimi
yellow
fur
yellow
dri
fur
slipperi
rapid
puls
therefor
therapeut
logic
clear
heat
detox
recommend
prescript
compris
almond
g
gypsum
g
predecoct
trichosanth
kirilowii
g
rhubarb
g
end
addit
ephedra
honey
fri
g
semen
lepidii
g
peach
kernel
g
amomum
tsaoko
g
arecanut
g
atractylod
lancea
g
yield
decoctionin
addit
recommend
chines
patent
medicin
xiyanp
inject
xuebij
injectionsever
stage
character
heat
toxin
gener
stasi
stage
clinic
manifest
known
high
fever
oppress
chest
anhel
purpleblack
facial
complexion
lip
dark
swollen
obnubil
crimson
tongu
yellow
dri
fur
surg
fine
rapid
stringlik
puls
thu
therapeut
logic
detox
dispers
blood
stasisth
recommend
prescript
three
yellow
gypsum
decoct
shang
jiang
powder
toxinresolv
bloodquicken
decoct
composit
compris
ephedra
honey
fri
g
almond
g
gypsum
g
periostracum
cicada
g
bombyx
batryticatu
g
rhizoma
curcuma
longa
g
rhubarb
stirfri
wine
g
scutellaria
baicalensi
g
copti
chinensi
g
phillyrin
g
angelica
sinensi
g
peach
kernel
g
radix
paeonia
rubra
g
rhizom
rehmannia
g
yield
decoctionth
recommend
chines
patent
medicin
xiyanp
inject
xuebij
inject
qingkail
inject
angong
niuhuang
pillsseverestag
character
inner
block
caus
collaps
stage
clinic
manifest
includ
dyspnea
pant
exert
need
assist
ventil
accompani
coma
agit
cold
limb
cold
sweat
dark
purpl
tongu
thick
dri
thick
tongu
fur
float
rootless
puls
thrapeut
logic
rescu
collaps
restor
yang
henc
recommend
prescript
compris
ginseng
g
aconitin
g
predecoct
cornu
officinali
g
yield
decoct
taken
fluid
suhexiang
pill
angong
niuhuang
pillsth
recommend
chines
patent
medicin
xuebij
inject
shenfu
inject
shengmai
injectionrecoverystag
present
lung
spleen
qi
defici
clinic
manifest
includ
short
breath
fatigu
hypodynamia
anorexia
nausea
vomit
glomu
full
weak
stool
ungratifi
loos
stool
pale
tendersoft
enlarg
tongu
slimi
white
tongu
fur
therefor
therapeut
logic
supplement
spleen
lungth
recommend
prescript
compris
rhizoma
pinellina
praeparata
g
dri
tangerin
orang
peel
g
codonopsi
pilosula
g
radix
astragali
preparata
g
poria
coco
g
agastach
rugosu
g
fructu
amomi
g
end
addit
yield
decoct
addit
recommend
chines
patent
medicin
pill
costu
amomum
six
nobl
ingredientsrecoverystag
character
defici
qi
yin
clinic
manifest
stage
gener
heat
sweat
chest
heat
vexat
qi
counterflow
retch
vomit
short
breath
lassitud
essencespirit
red
tongu
thin
tongu
fur
vacuou
puls
henc
therapeut
logic
boost
qi
nourish
yinth
recommend
prescript
zhuy
shigao
decoct
cogongrass
rhizom
rhizoma
phragmiti
composit
prescript
includ
bamboo
leaf
g
gypsum
g
predecoct
codonopsi
pilosula
g
radix
ophiopogoni
g
pinellia
ternat
g
cogongrass
rhizom
g
rhizoma
phragmiti
g
licoric
g
polish
roundgrain
rice
g
yield
decoctionth
recommend
chines
patent
medicin
shengmaiyin
treatment
principl
treat
patient
improv
symptom
underli
diseas
activ
prevent
potenti
complic
secondari
infect
provid
time
measur
support
organ
function
hypox
respiratori
failur
sever
ard
give
oxygen
therapi
immedi
patient
ard
close
monitor
sign
clinic
deterior
rapidli
progress
respiratori
failur
consid
sever
hypoxem
respiratori
failur
standard
oxygen
therapi
fail
patient
increas
frequenc
breath
timesmin
hypoxemia
mmhg
even
oxygen
deliv
via
face
mask
reservoir
bag
ga
flow
lmin
may
consid
hypox
respiratori
failureard
statu
sever
acut
hypox
respiratori
failur
caus
increas
pulmonari
capillari
permeabl
alveolar
epitheli
cell
damag
divid
mild
moder
sever
condit
accord
berlin
definit
tabl
hfno
support
standard
oxygen
therapi
maintain
still
hard
breath
rate
increas
rapidli
hfno
consid
hfno
deliv
lmin
ga
flow
gener
ga
flow
initi
set
lmin
oxygen
concentr
well
toler
coordin
set
adjust
accord
oxygen
statu
patient
compar
standard
oxygen
therapi
hfno
abl
reduc
chanc
tracheal
intub
patient
hypercapnia
like
exacerb
obstruct
lung
diseas
cardiogen
pulmonari
edema
hemodynam
instabl
multiorgan
failur
abnorm
mental
statu
given
hfno
hfno
may
safe
patient
mildmoder
nonworsen
hypercapnia
howev
respiratori
distress
still
exist
even
worsen
dramat
hfno
ga
flow
lmin
hour
respiratori
support
strategi
changedniv
niv
provid
certain
posit
pressur
ventil
effect
posit
pressur
form
close
mask
hfno
combin
intermitt
shortterm
niv
h
support
may
use
reduc
respiratori
power
consumpt
improv
oxygen
niv
guidelin
recommend
use
respiratori
support
therapi
hypoxem
respiratori
failur
pandem
viral
ill
limit
data
show
high
failur
rate
niv
mer
patient
invas
mechan
ventil
consid
case
ard
still
exist
even
acut
deterior
niv
process
h
patient
hemodynam
instabl
multipl
organ
failur
abnorm
mental
statu
receiv
nivinvas
mechan
ventil
support
hfno
demand
ga
flow
lmin
niv
ard
still
exist
even
acut
deterior
invas
mechan
ventil
implement
soon
possibleendotrach
intub
carri
train
experienc
provid
use
airborn
precaut
sinc
endotrach
intub
oper
may
produc
larg
number
contagi
aerosolsth
strategi
protect
lung
ventil
implement
invas
mechan
ventil
lower
tidal
volum
mlkg
lower
plateau
pressur
appropri
peep
patient
moderatesever
ard
recommend
use
higher
peep
appli
prone
ventil
h
per
day
adopt
deep
sedat
analgesia
muscl
relax
strategi
within
first
h
mechan
ventil
patient
sever
acut
hypox
respiratori
failur
pay
attent
prevent
ventilatorassoci
lung
injuri
mechan
ventilationextracorpor
life
support
ecl
process
invas
mechan
ventil
patient
still
state
hypoxia
combin
increas
partial
pressur
carbon
dioxid
exclud
ventil
dysfunct
mmhg
especi
muscl
relax
prone
ventil
necessari
consid
implement
ecl
howev
suggest
ecl
treatment
carri
condit
profession
center
access
expertis
current
ecl
icu
includ
vvecmo
blood
pump
femor
vein
return
right
atrium
intern
jugular
vein
oxygen
membran
oxygen
vaecmo
blood
pump
femor
vein
directli
enter
aortic
system
femor
arteri
oxygen
membran
oxygen
patient
sever
refractori
hypoxemia
neuromuscular
blockad
improv
oxygen
suppli
especi
still
evid
ventilatorpati
dyssynchroni
use
sed
howev
neuromuscular
blockad
continu
infus
routin
use
patient
moderatesever
ard
avail
ecmo
conjunct
low
tidalvolum
mechan
ventil
consid
treatment
patient
sever
refractori
hypoxemia
standard
therapi
fail
routin
use
highfrequ
oscillatori
ventil
hfov
patient
moderatesever
ard
benefici
may
harm
howev
hfov
may
still
regard
rescu
therapi
patient
sever
ard
refractori
hypoxemia
ecmo
use
sever
ard
patient
lung
injuri
score
ph
due
uncompens
hypercapnia
recommend
ard
patient
consid
use
extracorpor
carbon
dioxid
remov
ard
patient
support
research
evid
futur
conserv
fluid
manag
adopt
ard
patient
without
tissu
hypoperfus
use
vasoact
drug
improv
microcircul
empir
antibiot
target
suspect
potenti
infect
use
soon
possibl
blind
improp
combin
broadspectrum
antibiot
avoid
unless
special
reason
routin
use
corticosteroid
avoid
glucocorticoid
use
short
time
day
accord
degre
dyspnea
progress
chest
imag
appropri
recommend
dose
equival
mgkg
methylprednison
per
day
provid
intens
standard
support
care
critic
ill
patient
includ
prevent
deep
vein
thrombosi
stressinduc
gastrointestin
bleed
blood
glucos
control
enter
nutrit
provid
supplement
nutrit
fatti
acid
antioxid
recommend
inhal
intraven
betaadrenerg
agonist
recommend
promot
alveolar
fluid
clearanc
resolut
pulmonari
edema
recogn
septic
shock
infect
suspect
confirm
basi
full
fluid
resuscit
vasoconstrictor
drug
still
need
maintain
mean
arteri
pressur
map
mmhg
lactat
mmoll
exist
septic
shock
consid
lactat
monitor
reason
follow
three
manifest
chang
mental
state
oliguria
poor
peripher
perfus
prolong
capillari
fill
time
consid
sign
combin
infect
hypoperfusionin
resuscit
septic
shock
adult
least
mlkg
isoton
crystalloid
consid
adult
first
h
resuscit
septic
shock
children
give
mlkg
rapid
bolu
mlkg
first
aidisosmot
crystal
solut
recommend
resuscit
use
hypoton
crystalloid
starch
gelatin
resuscit
first
hour
albumin
may
consid
resuscit
fluid
recommend
base
low
qualiti
evid
certain
conditionsadminist
vasoconstrictor
suggest
shock
persist
fluid
resuscit
noradrenalin
first
choic
initi
blood
pressur
target
map
mmhg
adult
ageappropri
target
childrenif
possibl
place
central
venou
cathet
vasopressor
infus
peripher
vein
larg
vein
sign
extravas
local
tissu
necrosi
close
monitoredif
extravas
occur
stop
infus
vasopressor
also
administ
via
intraoss
needl
remov
vvecmo
oxygen
concentr
ecmo
airoxygen
mixer
drop
air
flow
rate
drop
ventil
strong
enough
last
h
respiratori
rate
within
breathsmin
normal
withdraw
vvecmo
may
consideredremov
vaecmo
blood
flow
rate
reduc
rate
l
min
everi
h
lmin
hemodynam
condit
stabl
blood
flow
rate
reduc
lmin
within
h
bridg
tube
arterioven
end
connect
bridg
tube
form
ecmo
circuit
selfcircul
bodi
hemodynam
driven
heart
hemodynam
stabl
least
h
consid
remov
machin
patient
well
awar
cough
reflex
obviou
suck
sputum
hemodynam
stabl
ventil
paramet
close
offlin
paramet
spontan
breath
test
sbt
perform
sbt
pass
invas
breath
consid
remov
endotrach
tube
patient
need
advanc
respiratori
support
hfno
niv
mv
ecl
etc
stabl
hemodynam
tissu
perfus
signific
impair
organ
function
need
organ
support
treatment
crrt
artifici
liver
etc
consid
transfer
patient
icu
procedur
bodi
temperatur
return
normal
day
respiratori
symptom
improv
significantli
inflamm
lung
show
obviou
sign
absorpt
respiratori
nucleic
acid
neg
two
consecut
time
oneday
sampl
time
interv
least
patient
releas
isol
see
tabl
strong
recommend
accord
principl
standard
prevent
tertiari
protect
personnel
enter
variou
zone
evalu
use
individu
inventori
tabl
accord
exposur
risk
level
chose
person
protect
equip
variou
level
necessari
person
protect
equip
worn
strictli
accord
instruct
use
one
time
tabl
strong
recommend
patient
home
isol
scheme
shown
tabl
patient
monitor
bodi
temperatur
ill
home
bodi
temperatur
continu
higher
breath
get
wors
seek
medic
treatment
time
addit
take
protect
measur
home
caregiv
also
monitor
bodi
temperatur
close
mild
patient
gener
use
nasal
cathet
mask
oxygen
adjust
oxygen
flow
appropri
accord
patient
condit
doctor
instruct
close
monitor
patient
breath
blood
oxygen
satur
oxygen
therapi
fail
reach
expect
effect
nurs
analyz
caus
comprehens
vigil
notifi
doctor
mild
patient
gener
use
antivir
drug
antibacteri
drug
bacteri
infect
exist
symptomat
treatment
doctor
advic
follow
accur
time
advers
reaction
oseltamivir
mainli
includ
nausea
vomit
diarrhea
abdomin
pain
bronchiti
cough
etc
advers
reaction
interferon
mainli
flulik
symptom
fever
fatigu
myalgia
headach
follow
mild
suppress
bone
marrow
attent
paid
identifi
chang
clinic
manifest
advers
drug
reaction
accord
patient
condit
provid
highprotein
highvitamin
carbohydratecontain
diet
eg
egg
fish
lean
meat
milk
etc
enough
nutrit
improv
physic
condit
take
good
care
patient
respond
patient
question
time
posit
encourag
patient
reduc
anxieti
fear
dynam
monitor
patient
vital
sign
waterelectrolyt
balanc
acidbas
balanc
function
variou
organ
monitor
patient
infect
indic
determin
occurr
complic
acut
respiratori
distress
syndrom
septic
shock
stress
ulcer
deep
vein
thrombosi
critic
ill
patient
mainli
use
oxygen
therapi
hfno
niv
invas
mechan
ventil
use
variou
oxygen
treatment
sequenti
manner
airway
breath
circuit
need
kept
open
effect
oxygen
treatment
need
monitor
dynam
time
skincar
product
need
use
reason
avoid
damag
nose
face
lip
pressur
use
highflow
nasal
cathet
inhal
oxygen
oxygen
flow
temperatur
humid
adjust
appropri
use
noninvas
mechan
ventil
patient
receiv
relev
health
educ
patient
instruct
inhal
nose
pressur
set
low
high
gradual
reach
target
valu
humanmachin
coordin
maxim
patient
conscious
respiratori
function
close
observ
patient
artifici
airway
establish
use
close
suction
tube
reduc
viru
spread
nurs
wear
goggl
face
shield
avoid
occup
exposur
patient
develop
moder
sever
ard
invas
mechan
ventil
combin
prone
posit
need
adopt
standard
oper
procedur
prone
posit
need
follow
time
cautiou
prevent
pressur
ulcer
fall
bed
tube
slippag
eye
damag
pressur
complic
patient
treat
ecmo
monitor
perform
oxygen
oxygen
chang
color
darker
indic
possibl
coagul
doctor
notifi
adjust
heparin
dose
necessari
oxygen
replac
necessari
coagul
function
need
monitor
dynam
includ
whole
set
coagul
dic
dissemin
intravascular
coagul
time
activ
partial
thromboplastin
etc
patient
close
observ
sign
bleed
bruis
skin
mucou
membran
bleed
nasal
caviti
oral
caviti
bloodi
sputum
hematuria
blood
stool
swell
abdomen
move
dull
size
bilater
pupil
make
sure
ecmo
pipelin
tightli
connect
firmli
fix
prevent
air
embol
pipelin
slippag
perform
oral
care
skin
care
assist
patient
use
toilet
take
eye
indwel
tube
rule
regul
asept
oper
isol
strictli
follow
prevent
ventilatorrel
pneumonia
catheterrel
sepsi
urinari
cathet
relat
urinari
tract
infect
secondari
infect
dynam
assess
patient
nutrit
risk
time
nutrit
support
given
need
patient
eat
diet
rich
protein
carbohydr
recommend
patient
eat
compat
enter
nutrit
given
enter
nutrit
soon
possibl
patient
incompat
enter
nutrit
parenter
nutrit
given
time
meet
energi
requir
psycholog
humanist
care
perform
high
prioriti
especi
awak
patient
psycholog
techniqu
like
mind
base
stress
reduct
adopt
reliev
patient
anxieti
panic
build
optimist
confid
overcom
diseas
guidelin
three
major
limit
firstli
time
limit
fulli
consid
clinic
issu
emerg
diseas
secondli
mani
evid
came
data
search
indirect
thirdli
recommend
base
evid
exist
guidelin
expert
experi
situat
strong
recommend
produc
base
lowqual
evid
lowqual
evid
highqual
evid
appear
like
chang
current
recommend
